| ［1］ |
Hook EW Rd. Syphilis［J］. Lancet, 2017, 389（10078）: 1550⁃1557. DOI: 10.1016/S0140⁃6736（16）32411⁃4.
|
| ［2］ |
World Health Organization. Global incidence and prevalence of selected curable sexually transmitted infections: 2008. World Health Organization［J］. Reproductive Health Matters, 2012, 20（40）: 207⁃209.
|
| ［3］ |
中国国家卫生计生委疾病预防控制局. 2016年全国法定传染病疫情概况［DB/OL］. ［2017⁃02⁃25］. http://www.nhfpc.gov.cn/jkj/s3578/201702/38ca5990f8a54ddf9ca6308fec406157. shtml.
|
| ［4］ |
Seña AC, Wolff M, Behets F, et al. Response to therapy following retreatment of serofast early syphilis patients with benzathine penicillin［J］. Clin Infect Dis, 2013, 56（3）: 420⁃422. DOI: 10.1093/cid/cis918.
|
| ［5］ |
Zhou P, Gu X, Lu H, et al. Re⁃evaluation of serological criteria for early syphilis treatment efficacy: progression to neurosyphilis despite therapy［J］. Sex Transm Infect, 2012, 88（5）: 342⁃345. DOI: 10.1136/sextrans⁃2011⁃050247.
|
| ［6］ |
Shi M, Peng RR, Gao Z, et al. Risk profiles of neurosyphilis in HIV⁃negative patients with primary, secondary and latent syphilis: implications for clinical intervention［J］. J Eur Acad Dermatol Venereol, 2016, 30（4）: 659⁃666. DOI: 10.1111/jdv.13514.
|
| ［7］ |
Workowski KA, Bolan GA, Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015［J］. MMWR Recomm Rep, 2015, 64（3）: 34⁃48.
|
| ［8］ |
Ghanem KG, Moore RD, Rompalo AM, et al. Antiretroviral therapy is associated with reduced serologic failure rates for syphilis among HIV⁃infected patients［J］. Clin Infect Dis, 2008, 47（2）: 258⁃265. DOI: 10.1086/589295.
|
| ［9］ |
Jinno S, Anker B, Kaur P, et al. Predictors of serological failure after treatment in HIV⁃infected patients with early syphilis in the emerging era of universal antiretroviral therapy use［J］. BMC Infect Dis, 2013, 13: 605. DOI: 10.1186/1471⁃2334⁃13⁃605.
|
| ［10］ |
Tittes J, Aichelburg MC, Antoniewicz L, et al. Enhanced therapy for primary and secondary syphilis: a longitudinal retrospective analysis of cure rates and associated factors［J］. Int J STD AIDS, 2013, 24（9）: 703⁃711. DOI: 10.1177/0956462413480721.
|
| ［11］ |
Wu BR, Tsai MS, Yang CJ, et al. Spirochetemia due to Treponema pallidum using polymerase⁃chain⁃reaction assays in patients with early syphilis: prevalence, associated factors and treatment response［J］. Clin Microbiol Infect, 2014, 20（8）: O524⁃527. DOI: 10.1111/1469⁃0691.12504.
|
| ［12］ |
Fiumara NJ. Serologic responses to treatment of 128 patients with late latent syphilis［J］. Sex Transm Dis, 1979, 6（4）: 243⁃246.
|
| ［13］ |
Romanowski B, Sutherland R, Fick GH, et al. Serologic response to treatment of infectious syphilis ［J］. Ann Intern Med, 1991, 114（12）: 1005⁃1009.
|
| ［14］ |
Fiumara NJ. Treatment of primary and secondary syphilis: serologic response［J］. J Am Acad Dermatol, 1986, 14（3）: 487⁃491.
|
| ［15］ |
Peng RR, Wu J, Zhao W, et al. Neutropenia induced by high⁃dose intravenous benzylpenicillin in treating neurosyphilis: does it really matter?［J］. PLoS Negl Trop Dis, 2017, 11（3）: e0005456. DOI: 10.1371/journal.pntd.0005456.
|
| ［16］ |
中国中西医结合学会皮肤性病专业委员会性病学组. 梅毒血清固定临床处理专家共识［J］. 中华皮肤科杂志, 2015, 48（11）: 753⁃755. DOI: 10.3760/cma.j.issn.0412⁃4030.2015.11.001.
|
| ［17］ |
周平玉. 对成人早期梅毒治疗方案及治疗后评估的思考［J］. 中华皮肤科杂志, 2009, 42（5）: 679⁃682.
|
| ［18］ |
Seña AC, Zhang XH, Li T, et al. A systematic review of syphilis serological treatment outcomes in HIV⁃infected and HIV⁃uninfected persons: rethinking the significance of serological non⁃responsiveness and the serofast state after therapy［J］. BMC Infect Dis, 2015, 15: 479. DOI: 10.1186/s12879⁃015⁃1209⁃0.
|
